Capvizr
News · All summaries
Healthcare & Life Sciences
Langlai
Series BUndisclosed
RoundSeries B
AmountUndisclosed
LeadCDH Investments
HQShenzhen, China
DateNovember 13, 2026
THE DEAL, AT A GLANCE

Langlai

From the announcement
Who is involvedBacked by CDH Investments, Shenzhen Capital GroupFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedLanglai raised Series B, announced 2026-11-13From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersLanglai's Series B is recorded at $0M in Unclassified, alongside a market context of 944 other funding rounds totaling $400273M in the trailing 30 days.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Langlai · Financing Record

Explore source-linked visual explanations for Langlai. Unsupported claims are withheld while source review continues.

Record 15995 · Recorded date: 2026-11-13

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime